NCT04022876 2022-10-10
A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)
Aileron Therapeutics, Inc.
Phase 1 Terminated
Clinical Trials
6 trialsNCT01187615 2014-07-08
Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer
Bayer
Phase 1 Terminated
NCT00216216 2011-05-02
Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer
Hoosier Cancer Research Network
Phase 2 Terminated
NCT00494026 2009-11-20
Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)
Eli Lilly and Company
Phase 2 Terminated
NCT00447421 2009-10-28
A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy
Eli Lilly and Company
Phase 1/2 Terminated
NCT00475657 2009-05-29
Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
Eli Lilly and Company
Phase 2 Terminated